Seeing Is Believing
DNA is currently covered by 2 analysts with an average price target of $3213.47. This is a potential upside of $3206.57 (46472.03%) from yesterday's end of day stock price of $6.9.
Ginkgo Bioworks Holdings's activity chart (see below) currently has 11 price targets and 20 ratings on display. The stock rating distribution of DNA is 66.67% SELL and 33.33% BUY.
Analysts average stock forecasts to be materialized ratio is 26.67% with an average time for these price targets to be met of 7.33 days.
Highest price target for DNA is $5, Lowest price target is $5, average price target is $5.
Most recent stock forecast was given by MARK MASSARO from BTIG on 12-Mar-2026.
Currently out of the existing stock ratings of DNA, 2 are a SELL (66.67%), 1 are a BUY (33.33%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell Since 23-Aug-2024
$5
$-1.9 (-27.54%)
$9
25 days ago
(12-Mar-2026)
2/5 (40%)
$-1.4 (-21.88%)
41
Buy Since 02-Mar-2022
$3
$-2.93 (-49.41%)
$120
1 years 6 months 20 days ago
(17-Sep-2024)
0/4 (0%)
$-3.81 (-55.95%)
Hold Since 04-Oct-2022
$40
1 years 7 months 17 days ago
(20-Aug-2024)
0/3 (0%)
$5.48 (15.87%)
Sell Since 20-Aug-2024
$7
$0.1 (1.45%)
1 years 7 months 17 days ago
(20-Aug-2024)
1/1 (100%)
$-0.71 (-9.21%)
10
Buy Since 14-Oct-2021
$100
$93.1 (1349.28%)
2 years 4 months 22 days ago
(15-Nov-2023)
1/2 (50%)
$37.6 (60.26%)
6
What is DNA (Ginkgo Bioworks Holdings) average time for price targets to be met?
Which analyst has the current highest performing score on DNA (Ginkgo Bioworks Holdings) with a proven track record?
Which analyst has the current lower performing score on DNA (Ginkgo Bioworks Holdings) with a proven track record?
Which analyst has the most public recommendations on DNA (Ginkgo Bioworks Holdings)?
Which analyst is the currently most bullish on DNA (Ginkgo Bioworks Holdings)?
Which analyst is the currently most reserved on DNA (Ginkgo Bioworks Holdings)?